BNET Industries
Market Cap:$56.9M
Last Fiscal Year Sales:$1.4M
- Public
- US
Dow Jones Description
PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). PURE's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area).
Number of Employees 15
Peer Companies
NAICS Code Pesticide and Other Agricultural Chemical Manufacturing: 325320
Recent Events
-
Swish and Enviro-Solutions to Launch SDC-Based Disinfectants in Canada and US
-
PURE Bioscience signs agreement with Richmont Sciences
-
BRIEF-Pure Bioscience reports full year results
News & Analysis
Filter by
government and pure bioscience - All News and Analysis
PURE Bioscience Reports Second Quarter Results; Accelerates Commercialization of Platform Technology
- 2005-03-18
SAN DIEGO -- PURE Bioscience (OTCBB:PURE), a developer and marketer of technology-based products in the bioscience and water treatment sectors, today reported revenues from continuing bioscience division operations of approximately $51,000 for the fiscal quarter ended January 31, 2005, compared with revenues of $54,800 in the same quarter last year....
PURE Bioscience Receives Key Product Registration from State of California; Long-Awaited Milestone Opens Doors for Nation-Wide Marketing and Sales of Powerful Disinfectant
- 2004-12-16
SAN DIEGO -- PURE Bioscience (OTCBB:PURE) today announced that its silver dihydrogen citrate-based hard surface disinfectant has been registered by the California Department of Pesticide Regulation. Axen30 hard surface disinfectant is also registered by the U.S. Environmental Protection Agency EPA and each of the 49 other states. Michael L....
PURE Bioscience Reports Year End Results
- 2004-10-29
SAN DIEGO -- PURE Bioscience (OTCBB:PURE) today reported revenues from continuing bioscience segment operations of approximately $263,500 for the fiscal year ended July 31, 2004, compared to revenues of $115,700 in the prior year. The Company announced a narrowing loss from continuing operations of ($2,823,600), or ($0.21) per share, compared...
Pesticide.net Publishes Article on PURE Bioscience's Antimicrobial Technology
- 2004-09-14
SAN DIEGO -- Leading Industry Journal Highlights Quick Kill, 24 Hour Residual and Low Toxicity of Silver Dihydrogen Citrate PURE Bioscience (OTCBB:PURE) today announced that the August 30, 2004 edition of Insider eJournalTM, a publication of Pesticide.netTM, features an article on PURE's silver dihydrogen citrate antimicrobial technology. Pesticide.net,...
PURE Bioscience Strengthens Intellectual Property Protection by Retaining McDermott Will & Emery
- 2004-08-03
SAN DIEGO -- Firm Partner Cathryn Campbell, Ph.D., to Focus on PURE's Silver Dihydrogen Citrate Pharmaceutical Patent Portfolio PURE Bioscience (OTCBB:PURE) today announced that it has retained the law firm of McDermott Will & Emery to fortify the intellectual property protection of its silver dihydrogen citrate technology. Firm...
PURE Bioscience Files Additional U.S. Patent on Silver Dihydrogen Citrate Technology; New Patent Covers Expanded Potential Uses of PURE's Axenohl Antimicrobial
- 2004-06-07
Business Editors/Health/Medical Writers SAN DIEGO--BUSINESS WIRE--June 7, 2004 PURE Bioscience (OTCBB:PURE) today announced that it has filed an additional United States patent covering multiple potential uses for its AxenohlR silver dihydrogen citrate antimicrobial technology including the treatment of specific types of bacteria, fungus and viruses, as well as...
Therapeutics Inc. Forms Development Team for PURE Bioscience's Axenohl Silver Dihydrogen Citrate Technology
- 2004-06-03
Health/Medical Writers/High-Tech Writers SAN DIEGO--BUSINESS WIRE--June 3, 2004 PURE Bioscience (OTCBB:PURE) today announced that Therapeutics Inc. has created an internal team to focus on the development and commercialization of healthcare products based on PURE Bioscience's AxenohlR silver dihydrogen citrate technology. Charles E. Holland, Ph.D., vice president, corporate...
- 1
Industry Transcripts by Seeking Alpha
-
Oil-Dri Corporation of America F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 09, 2009about ODC
-
AeroVironment Inc. F2Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 08, 2009about AVAV
-
NCI Building Systems, Inc. F4Q09 (Qtr End 11/01/09) Earnings Call Transcript
on Dec 08, 2009about NCS
-
Toro Company F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Dec 08, 2009about TTC
-
KMG Chemicals F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 07, 2009about KMGB
Glass Door
Manufacturing Industry Companies
| Company | Employer Rating |
| Alcoa |  |
| United Technologies | |
| BAE SYSTEMS (United Kingdom) | |
| Textron |  |
| Boeing | |
IndustryTop Rated
Presented by American Express